LEARN

Join us as we navigate the shadows, shedding light on the silent struggles that unfold in the darkness, offering a glimpse into the intricate tapestry of Parkinson's nighttime symptoms.

Parkinson’s is #1. Parkinson’s is fastest growing neurological disorder in the world. (CLICK FOR MORE FACTS ABOUT PARKINSON’S DISEASE)

What to say and what to avoid when striking up a conversation with a person with Parkinson’s READ MORE:

If medication or other therapies no longer control your symptoms, your doctor may suggest a surgical therapy like deep brain stimulation (DBS). DBS therapy is an adjustable therapy that uses an implantable system that includes a pulse generator with leads to block certain brain signals from causing your Parkinson’s symptoms.

DBS is a treatment used by hundreds of thousands of people1 diagnosed with Parkinson’s disease. DBS has been used for more than 20 years to help people with Parkinson’s and other movement disorders manage their symptoms. Learn more here

At AbbVie, our commitment to preserving personhood of people around the world living with Parkinson’s disease is unwavering. With more than three decades of experience in neuroscience, we are providing meaningful treatment options today and advancing innovation for the future. AbbVie's Neuroscience portfolio consists of approved therapies in neurological and psychiatric disorders, including migraine, Parkinson's disease, post-stroke spasticity, schizophrenia and others, along with a robust pipeline. Every challenge makes us more determined and drives us to discover and deliver advancements for those impacted by these conditions, their care partners, and clinicians.

For more information about AbbVie’s commitment to Neuroscience, click here.